Form 4: Evolus, Inc. Officer Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Rui Avelar, Chief Medical Officer & Head of Research and Development at Evolus, Inc., sold shares to cover tax withholding obligations related to vesting restricted stock units.
Summary
- On May 10, 2024, Rui Avelar, Chief Medical Officer & Head of Research and Development at Evolus, Inc., sold 3,441 shares of common stock.
- The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units.
- The shares were sold at a weighted average price of $12.7174, with individual trades ranging from $12.51 to $13.06.
- Following the transaction, Avelar directly owns 368,847 shares of Evolus, Inc.
Sentiment
Score: 5
Explanation: The document describes a routine transaction (sale of shares to cover taxes) and doesn't contain any information that would significantly impact investor sentiment positively or negatively.
Industry Context
Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among company executives and officers.
Key Dates
| Date | Description |
|---|---|
| 05/10/2024 | Date of the transaction: Rui Avelar sold shares of Evolus, Inc. common stock. |
| 05/14/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.